Illumina | ILMN - Operating Profit


Illumina reported $305M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Agilent USD 444M 45M Jun/2026
Bio Techne USD 55.82M 39.18M Sep/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Boston Scientific USD 1.01B 232M Sep/2026
Bruker USD 83.5M 13.9M Sep/2026
Charles River Laboratories USD 202.64M 82.75M Sep/2026
Danaher USD 1.25B 118M Sep/2026
Dentsply International USD 38M 46M Sep/2026
Edwards Lifesciences USD 542.7M 23.2M Sep/2026
Illumina USD 305M 45M Sep/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Laboratory Of America USD 418M 38.7M Sep/2026
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quest Diagnostics USD 479M 20M Sep/2026
Quidel USD 12.1M 27.4M Sep/2026
Repligen USD 24.31M 3.18M Sep/2026
Revvity USD 124.63M 1.51M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Standard Biotools USD -7.83M 1.59M Jun/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Waters USD -86M 234M Jun/2026